You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Von Willebrand Factor antibody [F8/86] (ab778)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab778? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab778 has been referenced in 3 publications.

  1. Chabot S et al. A novel antiangiogenic and vascular normalization therapy targeted against human CD160 receptor. J Exp Med 208:973-86 (2011). IHC. PubMed: 21482699
  2. Chen X et al. Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J Neuroinflammation 5:12 (2008). IHC-Fr; Rabbit. PubMed: 18387175
  3. Naiem M et al. The value of immunohistological screening in the production of monoclonal antibodies. J Immunol Methods 50:145-60 (1982). PubMed: 6806388

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"